{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:21:51Z","timestamp":1774682511120,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00210-024-03517-6","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T07:02:15Z","timestamp":1728457335000},"page":"3977-3984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of hydrophilic statins on adiponectin, leptin, visfatin, and vaspin levels in streptozocin-induced diabetic rats"],"prefix":"10.1007","volume":"398","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8656-8144","authenticated-orcid":false,"given":"Hacer Kayhan","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0371-6376","authenticated-orcid":false,"given":"Berjan","family":"Demirtas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"3517_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13104-018-3149-4","volume":"11","author":"Y Adams","year":"2018","unstructured":"Adams Y, Ofori EK, Asare-Anane H, Amanquah SD, Ababio GK, Abendau E, Nabia R (2018) Adipocytokines in obese Ghanaian subjects with or without type 2 diabetes. BMC Res Notes 11:109\u2013115. https:\/\/doi.org\/10.1186\/s13104-018-3149-4","journal-title":"BMC Res Notes"},{"issue":"2","key":"3517_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4183\/aeb.2020.136","volume":"16","author":"\u015eH Akta\u015f","year":"2020","unstructured":"Akta\u015f \u015eH, Pen\u00e7e HH, \u00d6z\u00e7elik F et al (2020) Vaspin, adiponectin and leptin levels in type 1 diabetic rats induced by streptozotocin. Acta Endocrinol (Buchar) 16(2):136\u2013141. https:\/\/doi.org\/10.4183\/aeb.2020.136","journal-title":"Acta Endocrinol (Buchar)"},{"key":"3517_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/CPAA.S42496","volume":"5","author":"SI Al-Azzam","year":"2013","unstructured":"Al-Azzam SI, Alzoubi KH, Abeeleh JA, Mhaidat NM, Abu-Abeeleh M (2013) Effect of statin therapy on vaspin levels in type 2 diabetic patients. Clin Pharmacol 5:33\u201338. https:\/\/doi.org\/10.2147\/CPAA.S42496","journal-title":"Clin Pharmacol"},{"key":"3517_CR4","doi-asserted-by":"publisher","unstructured":"Alexiadou K, Kokkinos A, Liatis S, Perrea D, Katsilambros N, Tentolouris N (2012) Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration. Hormones 11(4):444-450. https:\/\/doi.org\/10.14310\/horm.2002.1376","DOI":"10.14310\/horm.2002.1376"},{"issue":"1","key":"3517_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1758-5996-6-99","volume":"6","author":"Z Al-Hamodi","year":"2014","unstructured":"Al-Hamodi Z, Al-Habori M, Al-Meeri A, Saif-Ali R (2014) Association of adipokines, leptin\/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus. Diabetol Metab Syndr 6(1):99. https:\/\/doi.org\/10.1186\/1758-5996-6-99","journal-title":"Diabetol Metab Syndr"},{"issue":"27","key":"3517_CR6","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.2174\/1381612811319270014","volume":"19","author":"M Banach","year":"2013","unstructured":"Banach M, Malodobra-Mazur M, Gluba A, Katsiki N, Rysz J, Dobrzyn A (2013) Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance. Curr Pharm Des 19(27):4904\u201312","journal-title":"Curr Pharm Des"},{"key":"3517_CR7","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.2147\/DMSO.S376163","volume":"15","author":"JX Cheng","year":"2022","unstructured":"Cheng JX, Yu K (2022) New discovered adipokines associated with the pathogenesis of obesity and type 2 diabetes. Diabetes Metab Syndr Obes 15:2381\u20132389. https:\/\/doi.org\/10.2147\/DMSO.S376163","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3517_CR8","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.biopha.2017.01.146","volume":"88","author":"I Dhananjayan","year":"2017","unstructured":"Dhananjayan I, Kathiroli S, Subramani S, Veerasamy V (2017) Ameliorating effect of betanin, a natural chromoalkaloid by modulating hepatic carbohydrate metabolic enzyme activities and glycogen content in streptozotocin-nicotinamide induced experimental rats. Biomed. Pharmacother 88:1069\u20131079. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.146","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"3517_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/ijem.IJEM_491_15","volume":"22","author":"AG Diwan","year":"2018","unstructured":"Diwan AG, Kuvalakar AA, Dharamsi S, Vora AM, Nikam VA, Ghadje AA (2018) Correlation of serum adiponectin and leptin levels in obesity and type 2 diabetes mellitus. Indian J Endocr Metab 22(1):93\u201399. https:\/\/doi.org\/10.4103\/ijem.IJEM_491_15","journal-title":"Indian J Endocr Metab"},{"issue":"1","key":"3517_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.diabres.2006.07.031","volume":"76","author":"T Dogru","year":"2007","unstructured":"Dogru T, Sonmez A, Tasci I, Bozoglu E, Yilmaz MI, Genc H, Erdem G, Gok M, Bingol N, Kilic S, Ozgurtas T, Bingol S (2007) Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance. Diabetes Res Clin Pract 76(1):24\u201329. https:\/\/doi.org\/10.1016\/j.diabres.2006.07.031","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"3517_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jdi.14146","volume":"15","author":"C Dong","year":"2024","unstructured":"Dong C, Wu G, Li H, Qiao Y, Gao S (2024) Type 1 and type 2 diabetes mortality burden: predictions for 2030 based on Bayesian age-period-cohort analysis of China and global mortality burden from 1990 to 2019. J Diabetes Investig 15(5):623\u2013633. https:\/\/doi.org\/10.1111\/jdi.14146","journal-title":"J Diabetes Investig"},{"issue":"3","key":"3517_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3889\/oamjms.2017.065","volume":"5","author":"MH El Samahi","year":"2017","unstructured":"El Samahi MH, Ismail NA, Matter RM, Selim A, Ibrahim AA, Nabih W (2017) Study of visfatin level in type 1 diabetic children and adolescents. Maced J Med Sci 5(3):299\u2013304. https:\/\/doi.org\/10.3889\/oamjms.2017.065","journal-title":"Maced J Med Sci"},{"issue":"3","key":"3517_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1161\/01.cir.103.3.357","volume":"103","author":"DJ Freeman","year":"2001","unstructured":"Freeman DJ, Norrie J, Sattar N et al (2001) Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation 103(3):357\u2013362. https:\/\/doi.org\/10.1161\/01.cir.103.3.357","journal-title":"Circulation"},{"key":"3517_CR14","doi-asserted-by":"publisher","unstructured":"Freitas Lima LC, Braga VDA, do Socorro de Fran\u00e7a Silva M, et al (2015) Adipokines, diabetes and atherosclerosis: an inflammatory association. Front Physiol 6:304. https:\/\/doi.org\/10.3389\/fphys.2015.00304","DOI":"10.3389\/fphys.2015.00304"},{"issue":"1","key":"3517_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/13510002.2019.1624085","volume":"24","author":"K Gothandam","year":"2019","unstructured":"Gothandam K, Ganesan VS, Ayyasamy T, Ramalingam S (2019) Antioxidant potential of theaflavin ameliorates the activities of key enzymes of glucose metabolism in high fat diet and streptozotocin - induced diabetic rats. Redox Rep. 24(1):41\u201350. https:\/\/doi.org\/10.1080\/13510002.2019.1624085","journal-title":"Redox Rep."},{"issue":"4","key":"3517_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s13312-012-0041-5","volume":"49","author":"NM Habeeb","year":"2012","unstructured":"Habeeb NM, Youssef OI, Saab AA, El Hadidi ES (2012) Adiponectin as a marker of complications in type I diabetes. Indian Pediatr 49(4):277\u2013280. https:\/\/doi.org\/10.1007\/s13312-012-0041-5","journal-title":"Indian Pediatr"},{"issue":"2","key":"3517_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-060377","volume":"13","author":"X Hong","year":"2023","unstructured":"Hong X, Zhang X, You L, Li F, Lian H, Wang J, Mao N, Ren M, Li Y, Wang C (2023) Sun K (2023) Association between adiponectin and newly diagnosed type 2 diabetes in population with the clustering of obesity, dyslipidaemia and hypertension: a cross-sectional study. BMJ Open 13(2):e060377. https:\/\/doi.org\/10.1136\/bmjopen-2021-060377","journal-title":"BMJ Open"},{"issue":"2","key":"3517_CR18","first-page":"185","volume":"20","author":"MK Hussein","year":"2020","unstructured":"Hussein MK, Hamza AA, Ahmed AA (2020) Relation between visfatin, body mass \u0131ndex with \u0131nsulin resistance in type 2 diabetic Iraqi patients. Univ Thi-Qar J Med 20(2):185\u2013190","journal-title":"Univ Thi-Qar J Med"},{"issue":"4","key":"3517_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00592-011-0310-0","volume":"49","author":"NP Kadoglou","year":"2012","unstructured":"Kadoglou NP, Sailer N, Kapelouzou A, Lampropoulos S, Vitta I, Kostakis A, Liapis CD (2012) Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes. Acta Diabetol 49(4):269\u2013276. https:\/\/doi.org\/10.1007\/s00592-011-0310-0","journal-title":"Acta Diabetol"},{"issue":"3","key":"3517_CR20","first-page":"295","volume":"23","author":"H Karamifar","year":"2013","unstructured":"Karamifar H, Habibian N, Amirhakimi G, Karamizadeh Z, Alipour A (2013) Adiponectin is a good marker for metabolic state among type 1 diabetes mellitus patients. Iran J Pediatr 23(3):295\u2013301","journal-title":"Iran J Pediatr"},{"issue":"1","key":"3517_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2478\/acph-2024-0001","volume":"74","author":"H Kaya Kayhan","year":"2024","unstructured":"Kaya Kayhan H, Demirtas B, Yokus B et al (2024) Comparative effects of pravastatin and rosuvastatin on carbohydrate metabolism in an experimental diabetic rat model. Acta Pharm 74(1):117\u2013130. https:\/\/doi.org\/10.2478\/acph-2024-0001","journal-title":"Acta Pharm"},{"issue":"1","key":"3517_CR22","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.1038\/s41598-024-56395-6","volume":"14","author":"M Khaled","year":"2024","unstructured":"Khaled M, Salama RA, Aboughalia A, Tarek M, Mohamed Fawzy N (2024) Apigenin ameliorates genitourinary dysfunction in a type 1 diabetic rat model via Drp1 modulation. Sci Rep 14(1):5754. https:\/\/doi.org\/10.1038\/s41598-024-56395-6","journal-title":"Sci Rep"},{"issue":"1","key":"3517_CR23","doi-asserted-by":"publisher","first-page":"324","DOI":"10.21608\/ejhm.2022.2120225","volume":"86","author":"NM Khater","year":"2022","unstructured":"Khater NM, Abd ELrahman HM, Mohammed RH, Elashery MA (2022) Evaluation of serum visfatin in children and adolescent with type1 diabetes mellitus. Egypt J Hosp Med 86(1):324\u2013328. https:\/\/doi.org\/10.21608\/ejhm.2022.2120225","journal-title":"Egypt J Hosp Med"},{"issue":"8","key":"3517_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011320","volume":"8","author":"MJ Ko","year":"2019","unstructured":"Ko MJ, Jo AJ, Kim YJ et al (2019) Time-and dose-dependent association of statin use with risk of clinically relevant new-onset diabetes mellitus in primary prevention: a nationwide observational cohort study. JAHA 8(8):e011320. https:\/\/doi.org\/10.1161\/JAHA.118.011320","journal-title":"JAHA"},{"key":"3517_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.ijcard.2016.08.051","volume":"223","author":"KK Koh","year":"2016","unstructured":"Koh KK, Oh PC, Sakuma I, Lee Y, Han SH, Shin EK (2016) Rosuvastatin dose-dependently improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients. Int J Cardiol 223:488\u2013493","journal-title":"Int J Cardiol"},{"key":"3517_CR26","doi-asserted-by":"publisher","unstructured":"Kumar A, Gangwar R, Ahmad Zargar A, Kumar R, Sharma A (2024) Prevalence of diabetes in India: a review of IDF diabetes atlas 10th edition. Curr Diabetes Rev 20(1):105-114. https:\/\/doi.org\/10.2174\/1573399819666230413094200","DOI":"10.2174\/1573399819666230413094200"},{"issue":"7","key":"3517_CR27","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.3390\/cells10071710","volume":"10","author":"P Kurowska","year":"2021","unstructured":"Kurowska P, Mlyczy\u0144ska E, Dawid M, Jurek M, Klimczyk D, Dupont J, Rak A (2021) Vaspin (SERPINA12) expression and function in endocrine cells. Cells 10(7):1710. https:\/\/doi.org\/10.3390\/cells10071710","journal-title":"Cells"},{"issue":"1","key":"3517_CR28","doi-asserted-by":"publisher","first-page":"13542","DOI":"10.1038\/s41598-018-31923-3","volume":"8","author":"S Liu","year":"2018","unstructured":"Liu S, Duan R, Wu Y, Du F, Zhang J, Li X, Guo S, Wang M, Zhang Q, Li Y, Li N (2018) Effects of vaspin on \u0131nsulin resistance in rats and underlying mechanisms. Sci Rep 8(1):13542. https:\/\/doi.org\/10.1038\/s41598-018-31923-3","journal-title":"Sci Rep"},{"key":"3517_CR29","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.2337\/db06-0259","volume":"55","author":"A Lopez-Bermejo","year":"2006","unstructured":"Lopez-Bermejo A, Chico-Julia B, FernandezBalsells M et al (2006) Serum visfatin increases with progressive beta-cell deterioration. Diabetes 55:2871\u20132875. https:\/\/doi.org\/10.2337\/db06-0259","journal-title":"Diabetes"},{"issue":"7","key":"3517_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412\u2013419. https:\/\/doi.org\/10.1007\/BF00280883","journal-title":"Diabetologia"},{"issue":"5","key":"3517_CR31","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s00125-016-3898-3","volume":"59","author":"TH Meek","year":"2016","unstructured":"Meek TH, Morton GJ (2016) The role of leptin in diabetes: metabolic effects. Diabetologia 59(5):928\u2013932. https:\/\/doi.org\/10.1007\/s00125-016-3898-3","journal-title":"Diabetologia"},{"key":"3517_CR32","doi-asserted-by":"publisher","first-page":"1067853","DOI":"10.1155\/2018\/1067853","volume":"2018","author":"JJ Min","year":"2018","unstructured":"Min JJ, Shin BS, Lee JH et al (2018) Effects of pravastatin on type 1 diabetic rat heart with or without blood glycemic control. J Diabetes Res 2018:1067853. https:\/\/doi.org\/10.1155\/2018\/1067853","journal-title":"J Diabetes Res"},{"issue":"1","key":"3517_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5812\/ijem.6535","volume":"11","author":"G Mohammadzadeh","year":"2013","unstructured":"Mohammadzadeh G, Zorghami N (2013) Serum leptin levels is reduced in non-obese subjects with type 2 diabetes mellitus. Int J Endocrinol Metab 11(1):3\u201310. https:\/\/doi.org\/10.5812\/ijem.6535","journal-title":"Int J Endocrinol Metab"},{"key":"3517_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5625\/1ar.2016.32.3.160","volume":"32","author":"A Mostafavinia","year":"2016","unstructured":"Mostafavinia A, Amini A, Ghorishi SK, Pouriran R, Bayat M (2016) The effects of dosage and the routes of administrations of streptozotocin and alloxan on induction rate of typel diabetes mellitus and mortality rate in rats. Lab Anim Res 32:160\u2013165. https:\/\/doi.org\/10.5625\/1ar.2016.32.3.160","journal-title":"Lab Anim Res"},{"issue":"4","key":"3517_CR35","first-page":"444","volume":"10","author":"OU Onyemelukwe","year":"2020","unstructured":"Onyemelukwe OU, Ogoina D, Onyemelukwe GC (2020) Leptin concentrations in type 2 diabetes and non-diabetes Nigerian-Africans. Am J Cardiovasc Dis 10(4):444\u2013454","journal-title":"Am J Cardiovasc Dis"},{"issue":"3","key":"3517_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/biom13030508","volume":"13","author":"\u0141 Pilarski","year":"2023","unstructured":"Pilarski \u0141, Pelczy\u0144ska M, Koperska A, Seraszek-Jaros A, Szuli\u0144ska M, Bogda\u0144ski P (2023) Association of serum vaspin concentration with metabolic disorders in obese \u0131ndividuals. Biomolecules 13(3):508. https:\/\/doi.org\/10.3390\/biom13030508","journal-title":"Biomolecules"},{"issue":"6","key":"3517_CR37","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1111\/bcp.13086","volume":"82","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar A, Giua R, Pedone C (2016) Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Br J Clin Pharmacol 82(6):1674\u20131684. https:\/\/doi.org\/10.1111\/bcp.13086","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3517_CR38","doi-asserted-by":"publisher","DOI":"10.5812\/ircmj.23814","volume":"18","author":"Z Salemi","year":"2016","unstructured":"Salemi Z, Rafie E, Goodarzi MT, Ghaffari MA (2016) Effect of metformin, acarbose and their combination on the serum visfatin level in nicotinamide\/streptozocin-\u0131nduced type 2 diabetic rats. Iran Red Crescent Med J 18(3):e23814. https:\/\/doi.org\/10.5812\/ircmj.23814","journal-title":"Iran Red Crescent Med J"},{"issue":"1","key":"3517_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41598-020-57486-w","volume":"10","author":"P Seedevi","year":"2020","unstructured":"Seedevi P, Ramu Ganesa A, Moovendhan M, Mohan K, Sivasankar P, Loganathan S, Shanmugam A (2020) Anti-diabetic activity of crude polysaccharide and rhamnose-enriched polysaccharide from G. lithophila on streptozotocin (STZ)-induced in Wistar rats. Sci Rep 10(1):556. https:\/\/doi.org\/10.1038\/s41598-020-57486-w","journal-title":"Sci Rep"},{"issue":"9346","key":"3517_CR40","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","volume":"360","author":"J Shepherd","year":"2002","unstructured":"Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Westendorp RG (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER):a randomised controlled trial. Lancet 360(9346):1623\u20131630","journal-title":"Lancet"},{"issue":"2","key":"3517_CR41","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.14814\/phy2.13566","volume":"6","author":"P Singh","year":"2018","unstructured":"Singh P, Zhang Y, Sharma P, Covassin N, Soucek F, Friedman PA, Somers VK (2018) Statins decrease leptin expression in human white adipocytes. Physiol Rep 6(2):13566. https:\/\/doi.org\/10.14814\/phy2.13566","journal-title":"Physiol Rep"},{"issue":"3","key":"3517_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1055\/s-0036-1572523","volume":"27","author":"AP Sunjaya","year":"2018","unstructured":"Sunjaya AP, Sunjaya AF, Halim S, Ferdinal F (2018) Risk and benefits of statins in glucose control management of type II diabetes. Int J Angiol 27(3):121\u2013131. https:\/\/doi.org\/10.1055\/s-0036-1572523","journal-title":"Int J Angiol"},{"issue":"1","key":"3517_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2007.02.013","volume":"196","author":"T Takagi","year":"2008","unstructured":"Takagi T, Matsuda M, Abe M, Kobayashi H, Fukuhara A, Komuro R, Kihara S, Caslake MJ, McMahon A, Shepherd J, Funahashi T, Shimomura I (2008) Effect of pravastatin on the development of diabetes and adiponectin production. Atherosclerosis 196(1):114\u2013121. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.02.013","journal-title":"Atherosclerosis"},{"issue":"1","key":"3517_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.beem.2013.11.003","volume":"28","author":"C Tao","year":"2014","unstructured":"Tao C, Sifuentes A, Holland WL (2014) Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic \u03b2 cells and adipocytes. Best Pract Res Clin Endocrinol Metab 28(1):43\u201358. https:\/\/doi.org\/10.1016\/j.beem.2013.11.003","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"3517_CR45","doi-asserted-by":"publisher","first-page":"95","DOI":"10.14744\/hnhj.2019.62534","volume":"59","author":"E Ta\u015fdemir","year":"2019","unstructured":"Ta\u015fdemir E, Sermet A (2019) The relationship between plasma adipsin, adiponectin, vaspin, visfatin, and leptin levels with glucose metabolism and diabetes parameters. Haydarpasa Numune Med J 59(2):95\u2013103. https:\/\/doi.org\/10.14744\/hnhj.2019.62534","journal-title":"Haydarpasa Numune Med J"},{"issue":"3","key":"3517_CR46","doi-asserted-by":"publisher","first-page":"754","DOI":"10.2337\/diacare.28.3.754","volume":"28","author":"M von Eynatten","year":"2005","unstructured":"von Eynatten M, Schneider JG, Hadziselimovic S, Hamann A, Bierhaus A, Nawroth PP, Dugi KA (2005) Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes. Diabetes Care 28(3):754\u2013755. https:\/\/doi.org\/10.2337\/diacare.28.3.754","journal-title":"Diabetes Care"},{"issue":"4","key":"3517_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4239\/wjd.v1.i4.116","volume":"1","author":"D Wanders","year":"2010","unstructured":"Wanders D, Plaisance EP, Judd RL (2010) Pharmacological effects of lipid-lowering drugs on circulating adipokines. World J Diabetes 1(4):116\u2013128. https:\/\/doi.org\/10.4239\/wjd.v1.i4.116","journal-title":"World J Diabetes"},{"issue":"3","key":"3517_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/eje.0.1430293","volume":"143","author":"M Wauters","year":"2000","unstructured":"Wauters M, Considine RV, Van Gaal LF (2000) Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143(3):293\u2013311. https:\/\/doi.org\/10.1530\/eje.0.1430293","journal-title":"Eur J Endocrinol"},{"key":"3517_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111179","volume":"135","author":"R Werida","year":"2021","unstructured":"Werida R, Khairat I, Khedr NF (2021) Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia. Biomed Pharmacother 135:111179. https:\/\/doi.org\/10.1016\/j.biopha.2020.111179","journal-title":"Biomed Pharmacother"},{"key":"3517_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4172\/2368-0512.1000107","volume":"5","author":"R Werida","year":"2018","unstructured":"Werida R, Khedr L, El-Sisi AE, Salama M (2018) Effect of rosuvastatin on serum levels of vaspin and visfatin in patients with CAD. Curr Res Cardiol 5:26\u201329","journal-title":"Curr Res Cardiol"},{"issue":"1","key":"3517_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40360-022-00595-1","volume":"23","author":"D Xilifu","year":"2022","unstructured":"Xilifu D, Tuerxun Z, Nuermaimaiti B, Aili A, Rehemu N, Sun H, Zhang X (2022) Effects of rosuvastatin on serum glucose and insulin in hyperuricemic rats. BMC Pharmacol Toxicol 23(1):66","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"3517_CR52","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/ijms20051190","volume":"20","author":"H Yanai","year":"2019","unstructured":"Yanai H, Yoshida H (2019) Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: mechanisms and perspectives. Int J Mol Sci 20(5):1190. https:\/\/doi.org\/10.3390\/ijms20051190","journal-title":"Int J Mol Sci"},{"key":"3517_CR53","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00228-021-03239-1","volume":"8","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Curtis AJ, Ernst ME et al (2022) Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults. Eur J Clin Pharmacol 8:467\u2013476. https:\/\/doi.org\/10.1007\/s00228-021-03239-1","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03517-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03517-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03517-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:02:09Z","timestamp":1744149729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03517-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,9]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03517-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4455856\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,9]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Experiment was conducted according to the guidelines for the care and the use of laboratory animals. Ethical approval was obtained from the committee for animal experiments at the Dicle University Medical Research Center, Diyarbakir, Turkey (Approval No.:12\/04\/2019-41306).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}